Researcher.Life Logo

Clinical and Molecular Hepatology : Impact Factor & More

eISSN: 2287-285XpISSN: 2287-2728
JournalOpen Access

Key Metrics

CiteScore
8.9
Eigenfactor
0.001 - 0.005
H-Index
49
Impact Factor
5 - 10
SJR
Q1Hepatology
SNIP
1.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Molecular Hepatology

Clinical and Molecular Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher KOREAN ASSOC STUDY LIVER
Language English
Frequency Quarterly
Article Processing ChargesKRW 42000
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Clinical and Molecular Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Molecular Hepatology

Genetic and Genomic Insights Across the SLD Spectrum.
  • 29 Jun 2026
  • Clinical and molecular hepatology
Comparison of Clinical Practice Guidelines for Chronic Hepatitis B: Natural History Classification and Treatment Initiation.
  • 29 Jun 2026
  • Clinical and molecular hepatology
Chronic Viral Hepatitis with Concurrent MASLD: Dual Etiology Challenges.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Transitions from Combustible to Noncombustible Tobacco Use and Liver Outcomes in Steatotic Liver Disease.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Clinical utility of liquid biopsy in biliary tract cancer: Diagnosis to treatment monitoring.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Abnormal Lipid Status Attenuates the Protective Association of Vitamin E With Pediatric MASLD.
  • 18 Jun 2026
  • Clinical and molecular hepatology
Genetic and Genomic Insights Across the SLD Spectrum.
  • 29 Jun 2026
  • Clinical and molecular hepatology
Comparison of Clinical Practice Guidelines for Chronic Hepatitis B: Natural History Classification and Treatment Initiation.
  • 29 Jun 2026
  • Clinical and molecular hepatology
Chronic Viral Hepatitis with Concurrent MASLD: Dual Etiology Challenges.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Transitions from Combustible to Noncombustible Tobacco Use and Liver Outcomes in Steatotic Liver Disease.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Clinical utility of liquid biopsy in biliary tract cancer: Diagnosis to treatment monitoring.
  • 25 Jun 2026
  • Clinical and molecular hepatology
Abnormal Lipid Status Attenuates the Protective Association of Vitamin E With Pediatric MASLD.
  • 18 Jun 2026
  • Clinical and molecular hepatology

FAQs on Clinical and Molecular Hepatology